Skip to main content

Dogwood Therapeutics, Inc.

DWTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001818844

No open-market purchases or sales by Dogwood Therapeutics, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $6.16M in total; no superinvestor holds it.

13F holders, Q1 2021

Institutional positions in Dogwood Therapeutics, Inc. as of Mar 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
14
No complete 13F data for Q4 2020
Shares held
882.9K
No complete 13F data for Q4 2020
Total value
$5.06M
No complete 13F data for Q4 2020

Holders and value by quarter

Institutions reporting DWTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2021: 14 institutions
Q1 2021: 14 institutionsQ2 2021: 14 institutionsQ3 2021: 13 institutionsQ4 2021: 16 institutionsQ1 2022: 15 institutionsQ2 2022: 17 institutionsQ3 2022: 25 institutionsQ4 2022: 27 institutionsQ1 2023: 23 institutionsQ2 2023: 24 institutionsQ3 2023: 23 institutionsQ4 2023: 20 institutionsQ1 2024: 20 institutionsQ2 2024: 24 institutionsQ3 2024: 24 institutionsQ4 2024: 10 institutionsQ1 2025: 13 institutionsQ2 2025: 10 institutionsQ3 2025: 12 institutionsQ4 2025: 10 institutionsQ1 2026: 13 institutionsQ2 2026: 15 institutions
Value heldQ1 2021: $5.06M
Q1 2021: $5.06MQ2 2021: $5.58MQ3 2021: $5.30MQ4 2021: $4.85MQ1 2022: $4.91MQ2 2022: $4.80MQ3 2022: $485.7KQ4 2022: $307.7KQ1 2023: $307.1KQ2 2023: $1.08MQ3 2023: $766.3KQ4 2023: $493.4KQ1 2024: $324.9KQ2 2024: $212.0KQ3 2024: $180.3KQ4 2024: $76.5KQ1 2025: $409.8KQ2 2025: $207.5KQ3 2025: $299.5KQ4 2025: $292.0KQ1 2026: $7.64MQ2 2026: $6.16M
Institutions holding DWTX and their total value by quarter
QuarterHoldersValue
Q2 202615$6.16M
Q1 202613$7.64M
Q4 202510$292.0K
Q3 202512$299.5K
Q2 202510$207.5K
Q1 202513$409.8K
Q4 202410$76.5K
Q3 202424$180.3K
Q2 202424$212.0K
Q1 202420$324.9K
Q4 202320$493.4K
Q3 202323$766.3K
Q2 202324$1.08M
Q1 202323$307.1K
Q4 202227$307.7K
Q3 202225$485.7K
Q2 202217$4.80M
Q1 202215$4.91M
Q4 202116$4.85M
Q3 202113$5.30M
Q2 202114$5.58M
Q1 202114$5.06M

Institutions, Q1 2021

Shares, value and share of portfolio for each institution holding Dogwood Therapeutics, Inc..

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.

Institutions holding DWTX in Q1 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Masters Capital Management LLC600,000$3.44M0.63%––
Two Sigma Investments, LP107,334$615.0K0.00%––
PVG Asset Management Corp55,160$316.1K1.00%––
Two Sigma Advisers, LP37,100$213.0K0.00%––
Envestnet Asset Management Inc27,844$160.0K0.00%––
Cetera Advisors LLC23,523$135.0K0.00%––
Millennium Management LLC22,858$131.0K0.00%––
Advisor Group Holdings, Inc.3,604$21.0K0.00%––
Sowell Financial Services LLC3,043$15.0K0.00%––
Morgan Stanley1,000$6.00K0.00%––
BlackRock Inc.719$4.00K0.00%––
Tower Research Capital LLC (TRC)694$4.00K0.00%––
Wells Fargo & Company19$00.00%––
WealthShield Partners, LLC29$00.00%––